Paper Details

  1. Home
  2. Paper Details

The efficacy and safety of pimecrolimus 1% cream vs. sertaconazole 2% cream in the treatment of patients with facial seborrhoeic dermatitis: a randomized blinded trial.

Author: AzizzadehMaryam, BagheriBahador, PahlevanDaryoush

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Pimecrolimus cream was found to be more effective and less irritating than sertaconazole cream in treating facial seborrhoeic dermatitis (FSD) in a double-blind, active-controlled, randomized trial of 60 patients. Pimecrolimus led to a faster response, fewer adverse effects, and a lower relapse rate compared to sertaconazole.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Facial seborrhoeic dermatitis (FSD) is a chronic inflammatory skin disorder characterized by remission and exacerbation episodes. In most cases, FSD requires long-term treatment. AIM: To compare the efficacy and safety of pimecrolimus and sertaconazole in patients with FSD. METHODS: In...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/ced.15067

データ提供：米国国立医学図書館（NLM）

Seborrheic Dermatitis: Navigating the Desert of Skin Conditions

Seborrheic dermatitis is a common skin condition that can cause significant discomfort and affect an individual's self-esteem. This research investigates the efficacy and safety of two topical treatments for facial seborrheic dermatitis: pimecrolimus cream and sertaconazole cream.

The authors conduct a double-blind, randomized trial, comparing the effectiveness of these two treatments. Their meticulous approach, akin to a caravan carefully traversing a desert, reveals valuable insights into the best path for managing this skin condition.

Finding a Oasis of Relief: Pimecrolimus Shows Promise

The study reveals that pimecrolimus cream is significantly more effective than sertaconazole cream in reducing the severity of facial seborrheic dermatitis. This finding offers hope to those seeking effective treatment options for this common skin condition.

A Desert of Choices: Understanding the Implications

The research emphasizes the importance of considering both efficacy and safety when choosing a treatment. While pimecrolimus shows superior effectiveness, it's essential to weigh the benefits against potential side effects.

Dr.Camel's Conclusion

This study provides valuable insights into the treatment of facial seborrheic dermatitis. It highlights the importance of individualized care, considering both the effectiveness and safety of treatment options. As we navigate the desert of skin conditions, this research offers a guide for finding the best path towards clearer skin and improved well-being.

Date :
  1. Date Completed 2022-04-27
  2. Date Revised 2022-04-27
Further Info :

Pubmed ID

34910320

DOI: Digital Object Identifier

10.1111/ced.15067

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.